The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2024
Synopsis
Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths.
The global Neglected Tropical Diseases Drugs and Vaccine market was valued at US$ 345 million in 2023 and is anticipated to reach US$ 474.1 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The Neglected Tropical Diseases (NTDs) Drugs and Vaccine Market is driven by the pressing need to combat and eradicate diseases that predominantly affect marginalized and underserved populations in tropical regions. NTDs, which include diseases like malaria, dengue, and schistosomiasis, cause significant morbidity and mortality, making it imperative to develop treatments and vaccines. As global health initiatives and pharmaceutical companies focus on addressing NTDs, the demand for research, development, and access to effective drugs and vaccines continues to grow. However, a key challenge for this market is the need to overcome financial and regulatory hurdles that often hinder investment in NTD research and drug development. Ensuring equitable access to these treatments, addressing drug resistance, and overcoming logistic challenges in delivering vaccines to remote areas are ongoing obstacles. Additionally, the market faces competition from other health priorities and diseases, requiring sustained efforts to mobilize resources and global commitment to eliminate NTDs. Striking a balance between innovation, affordability, and accessibility while addressing the unique challenges of NTDs is crucial for the continued progress of the Neglected Tropical Diseases Drugs and Vaccine Market.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Diseases Drugs and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Diseases Drugs and Vaccine.
Report Scope
The Neglected Tropical Diseases Drugs and Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neglected Tropical Diseases Drugs and Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Diseases Drugs and Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Segment by Type
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Segment by Application
Drugs
Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths.
The global Neglected Tropical Diseases Drugs and Vaccine market was valued at US$ 345 million in 2023 and is anticipated to reach US$ 474.1 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The Neglected Tropical Diseases (NTDs) Drugs and Vaccine Market is driven by the pressing need to combat and eradicate diseases that predominantly affect marginalized and underserved populations in tropical regions. NTDs, which include diseases like malaria, dengue, and schistosomiasis, cause significant morbidity and mortality, making it imperative to develop treatments and vaccines. As global health initiatives and pharmaceutical companies focus on addressing NTDs, the demand for research, development, and access to effective drugs and vaccines continues to grow. However, a key challenge for this market is the need to overcome financial and regulatory hurdles that often hinder investment in NTD research and drug development. Ensuring equitable access to these treatments, addressing drug resistance, and overcoming logistic challenges in delivering vaccines to remote areas are ongoing obstacles. Additionally, the market faces competition from other health priorities and diseases, requiring sustained efforts to mobilize resources and global commitment to eliminate NTDs. Striking a balance between innovation, affordability, and accessibility while addressing the unique challenges of NTDs is crucial for the continued progress of the Neglected Tropical Diseases Drugs and Vaccine Market.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Diseases Drugs and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Diseases Drugs and Vaccine.
Report Scope
The Neglected Tropical Diseases Drugs and Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neglected Tropical Diseases Drugs and Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Diseases Drugs and Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Segment by Type
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Segment by Application
Drugs
Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Malaria
1.2.3 Ebola
1.2.4 Dengue
1.2.5 Chagas
1.2.6 Leishmaniasis
1.2.7 Other
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drugs
1.3.3 Vaccines
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2019-2030)
2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
2.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
2.3.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2019-2024)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2023
3.5 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
3.7 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2025-2030)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
9.4 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Artecef BV
11.1.1 Artecef BV Company Detail
11.1.2 Artecef BV Business Overview
11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.1.5 Artecef BV Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Detail
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.5.5 Sanofi-Aventis Recent Development
11.6 Ranbaxy Labs
11.6.1 Ranbaxy Labs Company Detail
11.6.2 Ranbaxy Labs Business Overview
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.6.5 Ranbaxy Labs Recent Development
11.7 Lupin
11.7.1 Lupin Company Detail
11.7.2 Lupin Business Overview
11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.7.5 Lupin Recent Development
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Detail
11.8.2 Macleods Pharmaceuticals Business Overview
11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.8.5 Macleods Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.9.5 Cipla Recent Development
11.10 Romark Laboratories
11.10.1 Romark Laboratories Company Detail
11.10.2 Romark Laboratories Business Overview
11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.10.5 Romark Laboratories Recent Development
11.11 Toyama Chemica
11.11.1 Toyama Chemica Company Detail
11.11.2 Toyama Chemica Business Overview
11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.11.5 Toyama Chemica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
